A generation of men has learned to take its biology seriously — to track, measure, intervene, and demand more of medicine than fee-for-service was ever willing to deliver. This has been a real achievement. It is also, for the man who has done the work, increasingly insufficient. What comes next requires a different kind of medicine.
Why don't I feel better?
Some of the most successful men in my consulting room are often the most disappointed.
Their cardiometabolic markers are clean. Their DEXA is in the 90th percentile. Their hormone panels are perfect. They have tracked their sleep, dialled their ApoB, taken the supplements, lifted heavy and eaten clean for a decade. They have done everything the longevity playbook recommends. And they sit across from me and ask the question no blood test can answer.
This is not a failure of treatment. It is a particular threshold — the point at which the most data-literate generation of men medicine has ever encountered begins to outgrow the medicine that brought them here.
I want to write about it carefully, because it would be easy to misread what I am saying.
Optimisation is foundational. And insufficient.
The preventive health and longevity movement has been a real achievement. A generation of men has learned to take its biology seriously — to track, measure, intervene, and demand more of its physicians than fee-for-service medicine was ever willing to deliver. Hormones and metabolic profile are no longer mysterious. The CGM sits beside the wedding ring. The wearable on the wrist tells the story the patient could not have told the doctor a decade ago. This is not foolishness. It is genuine medical literacy applied at scale, and it has made my work immeasurably easier than it was when men arrived hollowed out and undiagnosed at fifty.
I am not, in what follows, dismissing optimisation. I am making the harder argument: that it is foundational and insufficient, and that the order of those two words matters.
A lot of men have not yet done the work of optimisation. They are still suboptimal at the molecular layer — sleep-deprived, metabolically dysregulated, hormonally adrift, underscreened and undertreated. For them, the optimisation playbook is exactly the right medicine. The reader who has not yet done this work should do it before reading further.
Calibration, the move I am about to propose, does not work without it. You cannot calibrate a system that has not first been brought into reasonable order.
The ceiling is not a failure. It is a structural property of the medicine.
But for the man who has done the work — five to ten years pushing his biomarkers toward the optimal — something else begins to happen. The numbers continue to improve. The hollowness does not.
That is the ceiling of optimisation.
The ceiling is not a failure of the patient or the physician. It is a structural property of the medicine. I propose that a man drifts across four layers, each less reachable than the one beneath, and each feeding back into the others.
The first is molecular. Cells, hormones, microbiome, metabolism — the substrate the standard panel measures and the layer where pharmacology has its strongest reach. Even here, optimisation has an internal ceiling: the testosterone in circulation is one thing; the receptor that recognises it, the cofactors that translate it, the downstream cascade that converts it into effect, are another. A man can have his numbers in range and still experience reduced effect because the receiver itself has drifted.
The second is environmental. The body now operates in chemical and temporal conditions evolution did not anticipate — exogenous compounds deposited in tissue, hormonal pulsatility flattened by artificial light, sleep architectures structured around work rather than the sun. These are not failures of discipline. They are facts of the post-industrial environment. Lifestyle medicine reaches some of this; sustained behaviour change reaches more. Pharmacology, beyond managing a few inflammatory consequences, does not reach it directly.
The third is informational — the whole psychosocial environment: financial precarity, dopamine dysregulation, social isolation, relationship fragmentation. These are not just psychological experiences. They are also biological inputs. Chronic cortisol suppresses GnRH pulsatility. Dopamine dysregulation alters hypothalamic signalling. Social isolation impoverishes the microbiome. Pharmacology can stabilise the downstream consequences — but cannot reach the upstream cause.
The fourth is definitional and existential. Definitionally: the cultural symbols of male function — muscularity, strength, virility — have progressively detached from the biological and relational realities they once signalled. The physique is now engineered for display, rather than for hunting, cultivating, or building. The virility is performed, without the relational grounding of fertility and posterity. The markers lose their hold on identity when they no longer reference historical function. When the performance becomes futile, existential questions arise. These are questions that clinicians may not have the answers for.
The hollowness that arrives at the ceiling is the upstream drift at the second, third, and fourth layers. It is real. It is structural. And it is almost never named — because biological medicine has no instrument for it and no incentive to acknowledge what its tools cannot reach.
What lies beyond is not more optimisation. It is calibration.
What lies beyond the ceiling, then, is not more optimisation. I believe it is calibration.
Molecular
Cells, hormones, microbiome, metabolism. The substrate the standard panel measures.
Environmental
The chemical and temporal conditions evolution did not anticipate.
Informational
The psychosocial environment, and its biological inputs.
Definitional and existential
What the body means, when its cultural symbols have detached from biological function.
Calibration is the practice of integrating one's biology and psychosocial context, and its drift, to what the body actually means to him, and what well-being actually means to him — which may differ between men and may change through the different stages of life.
The forty-five-year-old father wants strength enough to carry his children for another decade. The chief executive wants cognitive stamina that will not be there at seventy. The man recovering from a cardiac scare wants longevity for grandchildren he has not yet met. The man exiting a marriage wants vitality for a second half of life he is only beginning to imagine. These are not the same optimum. Nor is the calibration of the castrated man with end-stage prostate cancer, navigating his advanced care plan.
They are calibrations — each individual, each negotiated, each requiring a physician relationship that holds the man across time and listens for what he actually wants his mortal body to do.
Optimisation pushes a number toward a ceiling.
Calibration asks the harder question: what configuration is right for this man, in this life, at this stage, given what he is drifting away from and what he is building toward?
The first is engineering. The second is medicine.
Where a different kind of medicine begins.
I am writing this for two readers.
The first is the man who has reached the ceiling and wants language for what he is experiencing. I hope this gives him some.
The second is my colleagues in preventive medicine, doing serious work helping many achieve better health. My thesis is that the biological ceiling is not where medicine ends.
It is where a different kind of medicine begins — one that requires a physician relationship attentive to all four layers, sustained across time, willing to explore questions that no panel was designed to answer.
That form of medicine has been quietly disappearing while the language of optimisation dominates our vocabulary. I suspect it is the form most people were looking for the whole time. And I suspect there is more interest in recovering it as the sector continues to evolve.